Quality Framework
Our Quality Framework
Independent third-party testing on selected lots through Janoshik Analytical (Czech Republic, ISO 17025). Reports published as each cycle completes — see the Janoshik wall on /coa.
+107 product lines covered by manufacturing spec
Manufacturing specs cover every product line we ship. Janoshik runs on rolling cycles (~2–3 weeks per report) against selected lots — each new report upgrades a class spec to measured third-party data.
What Janoshik tests for us
On the lots we publish: HPLC purity and identity. ICP-MS heavy metals on copper peptides as standard. LAL endotoxin and USP <61> sterility / bioburden are available as separate add-on panels and are noted on a report when present.
Our manufacturing batch specifications define purity, identity, and content thresholds for each product line. Sampled lots are independently verified via Janoshik. All analytical claims linked from /coa come from Janoshik reports.
What we don't do:CertaPeptides does not run HPLC, MS, LAL, or bioburden testing in-house. We don't publish per-vial measurement records. The published Janoshik reports are the analytical truth on this site; everything else is class-level specification.
Published Records
9 Janoshik reports + 107 manufacturing batch specifications. Janoshik entries link out to the public report; manufacturing entries link to the verify page.
116 records · Click a row to view full analytical data
| Batch # | Product | HPLC Purity | Test Date | Status | |
|---|---|---|---|---|---|
| 7A73FMWNNBXP | Glow Blend | Content quantification (Janoshik) | 2026-04-21 | PASS | |
| Z389R9WPGKD7 | BPC-157 + TB-500 | Content quantification (Janoshik) | 2026-04-21 | PASS | |
| JGERIBLDY5ZW | BPC-157 | 99.036% | 2026-04-20 | PASS | |
| U97KTF6W816F | GHK-Cu | 99.425% | 2026-04-20 | PASS | |
| 4S6XFDXXP8VD | Retatrutide | 99.702% | 2026-04-01 | PASS | |
| 4S6XFDXXP8VD | Retatrutide | 99.702% | 2026-04-01 | PASS | |
| 3N5W5GFN9ZJ9 | Selank | 99.788% | 2026-03-31 | PASS | |
| IT2JSP8AGYWZ | Ipamorelin | 99.766% | 2026-03-31 | PASS | |
| FMUB79QCK7BX | Epitalon | 98.005% | 2026-03-31 | PASS | |
| CP-2604-DHX20 | Dihexa 20mg | ≥98% (small molecule, by HPLC) | PASS | ||
| CP-2604-TPT10 | Teriparatide 10mg | ≥97% (recombinant peptide fragment, by HPLC) | PASS | ||
| CP-2604-HUM10 | Humanin 10mg | ≥98% (class spec) | PASS | ||
| CP-2604-KLO80 | Klow Blend 80mg | ≥98% (class spec) | PASS | ||
| CP-2604-PNL5 | Pinealon 5mg | ≥97% (short bioregulator peptide) | PASS | ||
| CP-2604-PNL10 | Pinealon 10mg | ≥97% (short bioregulator peptide) | PASS | ||
| CP-2604-PNL20 | Pinealon 20mg | ≥97% (short bioregulator peptide) | PASS | ||
| CP-2604-NEA5 | N-Acetyl Epitalon Amidate 5mg | ≥97% (modified bioregulator peptide) | PASS | ||
| CP-2604-PEP10 | PE 22-28 10mg | ≥97% (short bioregulator peptide) | PASS | ||
| CP-2604-ADM5 | Adamax 5mg | ≥97% (short bioregulator peptide) | PASS | ||
| CP-2604-KPV5 | KPV 5mg | ≥98% (class spec) | PASS | ||
| CP-2604-KPV10 | KPV 10mg | ≥98% (class spec) | PASS | ||
| CP-2605-VIP5 | VIP 5mg | ≥98% (class spec) | PASS | ||
| CP-2604-TIB18 | Tesamorelin + Ipamorelin Blend 18mg | ≥98% (class spec) | PASS | ||
| CP-2604-SSB20 | Semax + Selank Blend 20mg | ≥98% (class spec) | PASS | ||
| CP-2604-RCB10 | Retatrutide + Cagrilintide Blend 10mg | ≥98% (class spec) | PASS |
Verifying your batch
Every vial ships with a batch code printed on the label. Scan the QR or paste the code into /verify to see the manufacturing batch specification (or, when published, the underlying Janoshik report).
Logged-in customers also see the order context — which order shipped this batch, when it shipped, and the carrier+AWB.
Our ≥98% commitment
If a Janoshik report on a published lot returns below 98% HPLC purity, we refund or replace any unit from that lot on request. Our published reports run higher — see the Janoshik wall on /coa.